Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Growth rate of therapy drugs by Cadila Healthcare India 2020

As of August 2020, the Indian pharmaceutical company Cadila Healthcare saw its hormones drug segment grow at a whopping 40.9 percent. The company's gynaecological drug formulation, Mifegest Kit followed suite at a growth rate of a little over 37.9 percent and its cardiac drug Atorva therapy grew at almost 26 percent that year.

Growth rate of therapy drugs manufactured by Cadila Healthcare in India 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until December 20th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

September 2020

Region

India

Survey time period

2020

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.